The Symprove brand was launched in 2010 by Barry Smith on his farm in Farnham, Surrey; Barry discovered that his innovative probiotic formula could not only make the animals on his farm live disease-free lives without the need for antibiotics – but could work on human beings, too. Over the following decade, Symprove’s liquid supplement containing live, active multi-strain bacteria, and its patented delivery system allowing the bacteria to “arrive, survive and thrive” in the gut, was recognised as uniquely effective by some of the world’s leading academics.
Interest in how to improve gut health has grown exponentially in recent years, as advances in scientific research and medicine have continued to uncover how the diversity and balance of bacteria in the microbiome affects many conditions – not only gut conditions such as IBS and IBD, but Parkinson’s and dementia, cardiovascular conditions, mood and mental health. While the science is emerging, it has become clear that people with many different diseases tend to have a less diverse or unbalanced microbiome.
With customer feedback regularly describing Symprove as “life-changing”, it is unsurprising that the company’s daily-use, subscription product, sold primarily through its direct-to-consumer website, is growing rapidly through both consumer's increasing awareness and recommendations from doctors and nutritionists.
